| __timestamp | MannKind Corporation | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 100244000 | 1488000000 |
| Thursday, January 1, 2015 | 29674000 | 1525000000 |
| Friday, January 1, 2016 | 14917000 | 2111000000 |
| Sunday, January 1, 2017 | 14118000 | 1848000000 |
| Monday, January 1, 2018 | 8737000 | 1213000000 |
| Tuesday, January 1, 2019 | 6900000 | 1010000000 |
| Wednesday, January 1, 2020 | 6248000 | 997000000 |
| Friday, January 1, 2021 | 12312000 | 967000000 |
| Saturday, January 1, 2022 | 19721000 | 838000000 |
| Sunday, January 1, 2023 | 31283000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
Data in motion
In the competitive world of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Teva Pharmaceutical Industries Limited and MannKind Corporation have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Teva consistently allocated substantial resources to R&D, with expenditures peaking in 2016. Despite a 55% decrease in spending by 2023, Teva's investment remained robust, reflecting its strategic focus on maintaining a competitive edge. In contrast, MannKind's R&D spending saw a dramatic 69% decline from 2014 to 2016, followed by a gradual recovery, culminating in a 212% increase by 2023.
These trends highlight the dynamic nature of pharmaceutical R&D strategies, with Teva focusing on sustained investment and MannKind adapting to market challenges. As the industry evolves, these companies' R&D commitments will continue to shape their future success.
AbbVie Inc. vs Teva Pharmaceutical Industries Limited: Strategic Focus on R&D Spending
Sanofi vs Teva Pharmaceutical Industries Limited: Strategic Focus on R&D Spending
R&D Insights: How Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and MannKind Corporation
R&D Insights: How Alnylam Pharmaceuticals, Inc. and MannKind Corporation Allocate Funds
Teva Pharmaceutical Industries Limited or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
Teva Pharmaceutical Industries Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Jazz Pharmaceuticals plc
R&D Spending Showdown: Teva Pharmaceutical Industries Limited vs PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Soleno Therapeutics, Inc. or MannKind Corporation: Who Invests More in Innovation?